Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPS: Denosumab vs Alendronate Adherence in Osteoporosis
NCT00518531Phase 3Completed
- Sponsor
- Amgen
- Start
- Sep 2007
- Primary completion
- Jun 2009
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of denosumab in osteoporosis, sponsored by Amgen. Started Sep 2007; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00518531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518531.